Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2714.1000 87.75 (3.34%)

NSE Mar 21, 2025 15:31 PM

32.29% Gain from 52W Low

Volume: 1.1M

High volume today

Ajanta Pharma Ltd.

20 May 2020

2714.10

3.34%

Ajanta Pharma (BUY): Near-term growth concerns but demand outlook intact

Buy: Ajanta Pharma Ltd.

BOB Capital Markets Ltd.

Ajanta Pharma (AJP) posted strong Q4 revenue/EBITDA growth of 32%/31% YoY to Rs 6.8bn/Rs 1.7bn.

Ajanta Pharma Ltd. is trading above its 50 day SMA of 2669.0